David Newcombe

Methylenedioxymethamphetamine (MDMA) in Psychiatry

Journal of Clinical Psychopharmacology October 10, 2018 Susan Schenk, David Newcombe 53 citations

Abstract Background For a number of mental health disorders, including posttraumatic stress disorders (PTSD), there are not many available treatment options. Recently, there has been renewed interest in the potential of methylenedioxymethamphetamine (MDMA) to restore function for patients with these disorders. The primary hypothesis is that MDMA, via prosocial effects, increases the ability of...